Elser Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Sell
19,007
-6,817
-26% -$6.97M 0.99% 14
2026
Q1
$24.3M Sell
25,824
-398
-2% -$403K 1.18% 12
2025
Q4
$28.2M Buy
26,222
+6,374
+32% +$6.09M 20.38% 2
2025
Q3
$16.3M Sell
19,848
-981
-5% -$730K 19.61% 1
2025
Q2
$16.2M Buy
20,829
+119
+0.6% +$92.5K 20.25% 1
2025
Q1
$17.1M Buy
20,710
+1,165
+6% +$969K 23.67% 1
2024
Q4
$15.1M Sell
19,545
-282
-1% -$233K 0.9% 11
2024
Q3
$17.6M Buy
19,827
+708
+4% +$637K 25.49% 1
2024
Q2
$17.3M Buy
+19,119
New +$15.3M 2.89% 10

Other funds holding LLY

Elser Financial Planning's LLY Position: Q2 2026 in Review

Elser Financial Planning reduced its Eli Lilly (LLY) stake by 26% in Q2 2026, selling an estimated $6.97M and leaving 19,007 shares worth $22.8M. The position accounts for 0.99% of the portfolio, ranked #14.

Elser Financial Planning first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.2M in Q4 2025. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elser Financial Planning held 19,007 shares of Eli Lilly worth $22.8M as of Q2 2026.
  • Elser Financial Planning sold 6,817 Eli Lilly shares in Q2 2026, an estimated $6.97M.
  • Eli Lilly made up 0.99% of Elser Financial Planning's portfolio in Q2 2026, its #14 holding.
  • Elser Financial Planning first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Elser Financial Planning's Eli Lilly position peaked at $28.2M in Q4 2025.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elser Financial Planning's 13F filing for Q2 2026, filed 14 Jul 2026.